Related Experiment Video

Updated: Jun 16, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Targeting the autophagy pathway for cancer chemoprevention

Meredith A Steeves1, Frank C Dorsey, John L Cleveland

  • 1Department of Cancer Biology, The Scripps Research Institute-Florida, 130 Scripps Way, Jupiter, FL 33458, United States.

Current Opinion in Cell Biology
|January 26, 2010
PubMed

Insights

Autophagy, a cellular process, acts as a tumor suppressor by controlling cell growth and aiding immune response. Activating autophagy through diet or drugs shows promise for cancer prevention strategies.

Area of Science:

  • Cellular Biology
  • Oncology
  • Immunology

Background:

  • Autophagy is vital for cellular homeostasis, metabolic stress response, and reducing oxidative damage.
  • Autophagy deficiency is linked to increased tumor incidence, suggesting its role as a tumor suppressor.
  • Autophagy influences oncogene-induced senescence (OIS) and antigen presentation, critical for cancer cell elimination.

Purpose of the Study:

  • To explore the role of autophagy in cancer suppression.
  • To investigate autophagy activation as a potential chemoprevention strategy.
  • To identify methods for harnessing autophagy for cancer prevention.

Main Methods:

  • Review of existing literature on autophagy and cancer.
  • Analysis of data from autophagy-deficient and knockout models.
  • Examination of processes like OIS and antigen presentation in relation to autophagy.

Main Results:

  • Autophagy plays a role in suppressing tumor formation.
  • Autophagy limits cancer progression through OIS control and enhanced immune surveillance.
  • Activation of autophagy may prevent cancer development.

Conclusions:

  • Autophagy is a key player in cancer suppression.
  • Strategies to activate autophagy, including caloric restriction, dietary compounds, and pharmacological agents, are promising for cancer chemoprevention.

More Related Videos

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...